Heartflow, Inc. (NASDAQ:HTFL – Get Free Report) insider Campbell Rogers sold 16,918 shares of the company’s stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $24.67, for a total value of $417,367.06. Following the transaction, the insider directly owned 83,511 shares in the company, valued at $2,060,216.37. This represents a 16.85% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Campbell Rogers also recently made the following trade(s):
- On Thursday, October 22nd, Campbell Rogers sold 12,157 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total transaction of $668,756.57.
- On Friday, September 18th, Campbell Rogers sold 12,156 shares of Heartflow stock. The stock was sold at an average price of $50.15, for a total transaction of $609,623.40.
- On Tuesday, November 17th, Campbell Rogers sold 12,157 shares of Heartflow stock. The shares were sold at an average price of $46.39, for a total transaction of $563,963.23.
- On Tuesday, November 17th, Campbell Rogers sold 24,188 shares of Heartflow stock. The stock was sold at an average price of $46.39, for a total value of $1,122,081.32.
- On Thursday, October 22nd, Campbell Rogers sold 23,933 shares of Heartflow stock. The stock was sold at an average price of $55.01, for a total value of $1,316,554.33.
- On Friday, September 18th, Campbell Rogers sold 19,682 shares of Heartflow stock. The shares were sold at an average price of $50.15, for a total value of $987,052.30.
Heartflow Stock Performance
HTFL stock traded down $1.26 during midday trading on Thursday, hitting $44.63. 1,279,655 shares of the stock were exchanged, compared to its average volume of 1,615,683. The stock’s 50-day moving average price is $51.84 and its 200-day moving average price is $35.47. The stock has a market cap of $3.92 billion, a price-to-earnings ratio of -48.51 and a beta of 2.50. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $60.65.
Heartflow (NASDAQ:HTFL – Get Free Report) last posted its earnings results on Thursday, November 12th. The company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.18) by $0.15. The company had revenue of $72.86 million for the quarter. Heartflow had a negative return on equity of 20.53% and a negative net margin of 33.11%. During the same period last year, the company posted ($0.27) EPS. Research analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC lifted its stake in shares of Heartflow by 75.1% during the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after purchasing an additional 275 shares during the period. IFP Advisors Inc grew its position in shares of Heartflow by 844.7% in the third quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after purchasing an additional 718 shares during the period. Allworth Financial LP grew its position in shares of Heartflow by 56.5% in the third quarter. Allworth Financial LP now owns 828 shares of the company’s stock valued at $41,000 after purchasing an additional 299 shares during the period. Integrated Wealth Concepts LLC acquired a new position in Heartflow in the second quarter valued at $53,000. Finally, Essential Partners LLC acquired a new position in Heartflow in the first quarter valued at $57,000.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on HTFL. Piper Sandler reaffirmed an “overweight” rating and issued a $64.00 price target (up from $45.00) on shares of Heartflow in a report on Tuesday, October 20th. Stifel Nicolaus lifted their price objective on Heartflow from $45.00 to $70.00 and gave the stock a “buy” rating in a research report on Friday, November 13th. Morgan Stanley upped their target price on Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research note on Friday, August 14th. JPMorgan Chase & Co. increased their target price on Heartflow from $35.00 to $45.00 and gave the company an “overweight” rating in a report on Friday, August 14th. Finally, Wells Fargo & Company raised their price target on Heartflow from $39.00 to $70.00 and gave the stock an “overweight” rating in a research report on Friday, November 13th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $60.12.
Read Our Latest Research Report on Heartflow
Heartflow Company Profile
HeartFlow, Inc. is a medical technology company that develops noninvasive tools to help clinicians assess coronary artery disease. Its platform analyzes coronary CT angiography scans to create personalized models of a patient’s coronary arteries and provide information that can support diagnosis and treatment planning. The company’s offerings include HeartFlow FFR CT Analysis, which estimates blood flow and the effects of artery narrowing, and tools for assessing coronary plaque. The technology combines medical imaging with computational analysis and artificial intelligence, giving clinicians information without requiring an invasive procedure to measure blood flow.
Recommended Stories
- Five stocks we like better than Heartflow
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for Heartflow Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heartflow and related companies with MarketBeat.com's FREE daily email newsletter.
